{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:48:51Z","timestamp":1775929731590,"version":"3.50.1"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2026,3,27]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To propose an integrative clinical\u2013biological hypothesis whereby progressive functional deterioration in advanced cancer constitutes the final common pathway of systemic decline, driven by persistent inflammation, catabolic metabolic dysregulation and impairment of stress\u2013response systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Narrative synthesis drawing on observations from established prognostic models (eg, Palliative Prognostic Score, Palliative Prognostic Index) and translational evidence concerning systemic inflammation, cachexia, metabolic mediators and stress-system dysregulation in advanced malignancy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Performance status measures\u2014Eastern Cooperative Oncology Group (ECOG) Performance Status, Karnofsky Performance Status and Palliative Performance Scale\u2014consistently demonstrate independent and often dominant prognostic value across diverse clinical settings and modelling strategies. Converging clinical and biological observations suggest that progressive functional decline reflects cumulative erosion of physiological reserve and adaptive capacity, mediated by persistent low-grade systemic inflammation, a predominantly catabolic metabolic state and chronic dysregulation of stress\u2013response pathways. This interplay leads to diminished homeostatic flexibility, resulting in disproportionate decompensation to minor intercurrent stressors and acceleration of terminal decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Functional status may represent more than a descriptive prognostic indicator; it could embody the clinical manifestation of progressive loss of systemic resilience. The proposed resilience\u2013threshold model frames a non-linear trajectory, leading to irreversible functional collapse once a critical threshold of adaptive reserve is exceeded. This conceptual framework has the potential to refine prognostic interpretation, inform proportionate therapeutic decisions and encourage prospective validation in palliative oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/spcare-2026-006184","type":"journal-article","created":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:20:15Z","timestamp":1775928015000},"page":"spcare-2026-006184","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Functional status and prognosis: the final common pathway in advanced cancer\u2014an integrative clinical\u2013biological hypothesis"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-8510","authenticated-orcid":false,"given":"Juan","family":"Santos Su\u00e1rez","sequence":"first","affiliation":[{"name":"Palliative Care, Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,4,11]]},"reference":[{"key":"2026041110200817000_spcare-2026-006184v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L"},{"key":"2026041110200817000_spcare-2026-006184v1.2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"2026041110200817000_spcare-2026-006184v1.3","doi-asserted-by":"publisher","DOI":"10.1177\/082585979601200102"},{"key":"2026041110200817000_spcare-2026-006184v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00145-6"},{"key":"2026041110200817000_spcare-2026-006184v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(98)00146-8"},{"key":"2026041110200817000_spcare-2026-006184v1.6","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050242"},{"key":"2026041110200817000_spcare-2026-006184v1.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d4920","article-title":"Development of prognosis in palliative care study (PiPS) predictor models to improve prognostication in advanced cancer: prospective cohort study","volume":"343","author":"Gwilliam","year":"2011","journal-title":"BMJ"},{"key":"2026041110200817000_spcare-2026-006184v1.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjspcare-2018-001702","article-title":"PROgnostic Model for Advanced Cancer (PRO-MAC)","volume":"10","author":"Hum","year":"2020","journal-title":"BMJ Support Palliat Care"},{"key":"2026041110200817000_spcare-2026-006184v1.9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1768","article-title":"Development and Validation of a Prognostic Survival Model With Patient-Reported Outcomes for Patients With Cancer","volume":"3","author":"Seow","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2026041110200817000_spcare-2026-006184v1.10","doi-asserted-by":"crossref","unstructured":"Souza-Silva R de , Calixto-Lima L , Varea Maria Wiegert E , et al . Decision tree algorithm to predict mortality in incurable cancer: a new prognostic model. BMJ Support Palliat Care 2024. doi:10.1136\/spcare-2023-004581","DOI":"10.1136\/spcare-2023-004581"},{"key":"2026041110200817000_spcare-2026-006184v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1878-4"},{"key":"2026041110200817000_spcare-2026-006184v1.12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12033","article-title":"Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients","volume":"6","author":"Lerner","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026041110200817000_spcare-2026-006184v1.13","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/jcsm.12209","article-title":"Circulating Activin A predicts survival in cancer patients","volume":"8","author":"Loumaye","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2026041110200817000_spcare-2026-006184v1.14","first-page":"454","article-title":"Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy","volume":"17","author":"Grim-Stieger","year":"2008","journal-title":"Eur J Cancer Care (Engl)"},{"key":"2026041110200817000_spcare-2026-006184v1.15","first-page":"e243","article-title":"Inflammation and performance status: the cornerstones of prognosis in advanced cancer","volume":"65","author":"Laird","year":"2023","journal-title":"J Pain Symptom Manage"},{"key":"2026041110200817000_spcare-2026-006184v1.16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1066"},{"key":"2026041110200817000_spcare-2026-006184v1.17","article-title":"Prognostic value of performance status, albumin, and CRP in last-line chemotherapy for pancreatic vs. other gastrointestinal cancers\u2014simple tools matter","volume":"16","author":"Ullenhag","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026041110200817000_spcare-2026-006184v1.18","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-4318"},{"key":"2026041110200817000_spcare-2026-006184v1.19","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_389942","article-title":"Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach","volume":"43","author":"Kadakia","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2026-006184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T17:20:18Z","timestamp":1775928018000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2026-006184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,11]]},"references-count":19,"alternative-id":["10.1136\/spcare-2026-006184"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2026-006184","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"value":"2045-435X","type":"print"},{"value":"2045-4368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,11]]}}}